Deerfield Management Company, L.P. (Series C) Iveric Bio, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $35.9 Million - $47.2 Million	-1,920,274 Reduced 56.07%	1,504,578 $36.6 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $14.1 Million - $19.6 Million	-819,246 Reduced 19.3%	3,424,852 $73.3 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $9.12 Million - $18 Million	-969,902 Reduced 18.6%	4,244,098 $76.1 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $2.94 Million - $6.09 Million	322,004 Added 6.58%	5,214,000 $50.2 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $1.59 Million - $2.2 Million	130,858 Added 2.75%	4,891,996 $82.3 Million
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $1.42 Million - $1.93 Million	-102,587 Reduced 2.11%	4,761,138 $79.6 Million
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $6.39 Million - $15.8 Million	-903,684 Reduced 15.67%	4,863,725 $79 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $10.7 Million - $23.1 Million	3,500,000 Added 154.36%	5,767,409 $29.4 Million
Q1 2020 May 15, 2020	BUY	$2.83 - $8.44 $3.59 Million - $10.7 Million	1,267,409 Added 126.74%	2,267,409 $7.8 Million
Q4 2019 Feb 14, 2020	BUY	$0.93 - $8.58 $930,000 - $8.58 Million	1,000,000 New	1,000,000 $8.58 Million

Others Institutions Holding ISEE

# of Institutions

Shares Held

250K

Call Options Held

40K

Put Options Held

View Full List

About IVERIC bio, Inc.

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

More about ISEE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account